![Foto de JUAN JOSE](/img/nophoto.png)
JUAN JOSE
NIETO FONTARIGO
Investigador contratado Ramón y Cajal
Publicaciones (22) Publicaciones de JUAN JOSE NIETO FONTARIGO
2024
-
Tezepelumab decreases airway epithelial IL-33 and T2-inflammation in response to viral stimulation in patients with asthma
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 79, Núm. 3, pp. 656-666
2023
-
Airway hyperresponsiveness reflects corticosteroid-sensitive mast cell involvement across asthma phenotypes
Journal of Allergy and Clinical Immunology, Vol. 152, Núm. 1, pp. 107-116.e4
-
Allergen Immunotherapy Enhances Airway Epithelial Antiviral Immunity in Patients with Allergic Asthma (VITAL Study): A Double-Blind Randomized Controlled Trial
American journal of respiratory and critical care medicine, Vol. 207, Núm. 9, pp. 1161-1170
-
C57Bl/6N mice have an attenuated lung inflammatory response to dsRNA compared to C57Bl/6J and BALB/c mice
Journal of Inflammation (United Kingdom), Vol. 20, Núm. 1
-
Identification of Asthma Phenotypes in the Spanish MEGA Cohort Study Using Cluster Analysis
Archivos de Bronconeumologia, Vol. 59, Núm. 4, pp. 223-231
-
Prognostic Usefulness of Basic Analytical Data in Chronic Obstructive Pulmonary Disease Exacerbation
Open Respiratory Archives, Vol. 5, Núm. 4
-
Serum exosome inflamma-miRs are surrogate biomarkers for asthma phenotype and severity
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 78, Núm. 1, pp. 141-155
2022
-
Association of rhinitis with asthma prevalence and severity
Scientific Reports, Vol. 12, Núm. 1
-
House dust mite sensitization and exposure affects bronchial epithelial anti-microbial response to viral stimuli in patients with asthma
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 77, Núm. 8, pp. 2498-2508
-
Phenotype and severity of asthma determines bronchial epithelial immune responses to a viral mimic
The European respiratory journal, Vol. 60, Núm. 1
-
Proteomic analysis of food allergens
Food Proteomics: Technological Advances, Current Applications and Future Perspectives (Elsevier), pp. 225-300
-
The polyhedric reality of the interaction between COVID-19, asthma and inhaled corticosteroids
ERJ Open Research
2021
-
Efficacy of mepolizumab in usual clinical practice and characteristics of responders: Mepolizumab in usual clinical practice
Respiratory Medicine, Vol. 187
-
Imiquimod Boosts Interferon Response, and Decreases ACE2 and Pro-Inflammatory Response of Human Bronchial Epithelium in Asthma
Frontiers in Immunology, Vol. 12
2020
-
Obesity does not increase the risk of Asthma readmissions
Journal of Clinical Medicine, Vol. 9, Núm. 1
-
iTRAQ-based proteomic analysis reveals potential serum biomarkers of allergic and nonallergic asthma
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 75, Núm. 12, pp. 3171-3183
2019
-
Expansion of different subpopulations of CD26 −/low T cells in allergic and non-allergic asthmatics
Scientific Reports, Vol. 9, Núm. 1
-
Blood eosinophils could be useful as a biomarker in chronic obstructive pulmonary disease exacerbations
International Journal of Clinical Practice, Vol. 73, Núm. 12
-
CD26 and Asthma: a Comprehensive Review
Clinical Reviews in Allergy and Immunology, Vol. 56, Núm. 2, pp. 139-160
2018
-
Association between blood eosinophil count with asthma hospital readmissions
European Journal of Internal Medicine, Vol. 53, pp. 34-39